Today: 19 May 2026
Salesforce stock price at $212: what to watch before Monday’s open
1 February 2026
2 mins read

Salesforce stock price at $212: what to watch before Monday’s open

New York, Feb 1, 2026, 16:12 EST — The market has closed for the day.

  • CRM ended Friday at $212.29, slipping 0.8%, and edged lower in after-hours trading.
  • This week’s crowded slate of megacap earnings and the Feb. 6 U.S. jobs report might shake up software sentiment.
  • Investors continue to digest Salesforce’s $5.6 billion military modernization contract and what it means for revenue recognition timing.

Salesforce shares closed Friday down 0.8% at $212.29, then dipped another 0.3% in after-hours trading. Roughly 11.1 million shares traded during the regular session.

The Dow slipped 0.36%, the S&P 500 dipped 0.43%, and the Nasdaq tumbled 0.94% as investors reacted to Donald Trump’s nomination of Kevin Warsh to head the Federal Reserve, alongside a hotter-than-expected producer-price report. “All these factors at once is more than the markets can digest,” said Michael Hans, chief investment officer at Citizens Wealth. Reuters

About a quarter of S&P 500 firms, including Alphabet and Amazon, report results next week. The Feb. 6 U.S. jobs report also looms, potentially shifting risk appetite after Microsoft’s cloud update rattled confidence in heavily hyped stocks. “For those companies where expectations have become very, very lofty, the onus is going to be on them to deliver,” said Jim Baird, chief investment officer at Plante Moran Financial Advisors. Reuters

Salesforce recently announced it landed a $5.6 billion, 10-year IDIQ contract from the U.S. Army, awarded through Computable Insights LLC, the company said. The IDIQ—meaning “indefinite delivery, indefinite quantity”—places a spending cap but doesn’t guarantee total outlays. Salesforce noted the financial effects will hit as orders come in, with more specifics expected on its upcoming Q4 earnings call. “From recruiting to the tactical edge, Salesforce is equipping our forces with technology built for today’s dynamic environments,” said Kendall Collins. IDC analyst Alan Webber described the deal as a “shift from buying software.” Salesforce Investor Relations

Software stocks stumbled early this week after SAP’s cloud forecast and a sharp drop in ServiceNow shares reignited fears that AI-first firms are squeezing subscription vendors. Salesforce tumbled 7.1% that day, Reuters reported. J.P. Morgan analysts noted the “malaise in software sentiment persists,” while Adam Turnquist at LPL Financial suggested the market was “pricing a worst-case scenario.” Reuters

Salesforce is now trading like a software stock that’s highly sensitive to macro moves: changes in rates, risk appetite, or AI spending stories hit the share price fast. On Monday, traders will be looking to see if dip buyers step in or if it sparks yet another wave of “show me” selling.

Salesforce disclosed granting 139,574 restricted stock units (RSUs) to employees who joined through its acquisitions of Apromore, Spindle AI, and Informatica under an inducement plan. These RSUs, which vest over time, will contribute to share-based compensation costs.

The Army award caps potential, rather than guarantees business, and government contracts often come in fits and starts. If the upcoming earnings call signals caution on enterprise demand — or casts “agentic” AI (software capable of acting within systems, not just responding to prompts) as a cost-heavy gamble — the stock may have trouble holding steady.

Walt Disney, Advanced Micro Devices, Alphabet, and Amazon headline the earnings calendar for the week of Feb. 2–6, steering the spotlight onto big-tech insights around cloud services and spending patterns. For software firms such as Salesforce, these broader signals can be just as crucial as their own results in the near term.

Nasdaq shows Salesforce’s next earnings date as an estimated Feb. 25, based on an algorithm since the company hasn’t confirmed the timing yet. That report is CRM’s next major trigger, with eyes on demand indicators, early revenue clues from the Army deal, and fresh guidance for the fiscal year ahead.

Stock Market Today

  • Chart Patterns Signal Potential Rise in Treasury Yields Amid New Interest Rate Era
    May 19, 2026, 7:15 AM EDT. A "pennant" chart pattern suggests U.S. Treasury yields could climb significantly, indicating a possible shift to a higher interest rate environment. Treasury yields, which reflect government borrowing costs and influence borrowing rates economy-wide, have remained volatile amid economic uncertainty. The pattern warns investors to brace for rising rates, which could pressure bonds and stocks. However, analysts note an alternative scenario where yields might not surge as much, adding complexity to market outlooks. This development underscores the challenges in forecasting fixed income markets and the potential for renewed volatility.

Latest articles

Meiwu Technology Stock Jumps 88% Premarket After Monday Rout — What’s Moving WNW Now

Meiwu Technology Stock Jumps 88% Premarket After Monday Rout — What’s Moving WNW Now

19 May 2026
Meiwu Technology shares surged 87.99% to $4.531 in premarket trading Tuesday after a 22.76% drop Monday, which left the stock at $2.410. The company recently raised $15.65 million in a private share sale at $0.626 per share, with proceeds earmarked for an AI-driven skincare platform and related projects. Meiwu reported 2025 revenue of $7.08 million and a net loss of $18.59 million.
Standard Chartered’s Push Into AI May Cut 7,000 Jobs as Bank Looks for 18% Returns

Standard Chartered’s Push Into AI May Cut 7,000 Jobs as Bank Looks for 18% Returns

19 May 2026
Standard Chartered will cut over 7,000 jobs by 2030 and aims for an 18% return on tangible equity, focusing on AI and automation to boost efficiency. The bank reported record Q1 operating income of $5.9 billion and profit before tax of $2.5 billion. Job cuts will mainly affect corporate and support roles in hubs like Bengaluru, Tianjin, and Warsaw. The bank seeks to attract $200 billion in new wealth by 2028.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Bank of China A-shares face Monday test after China PMI slides below 50
Previous Story

Bank of China A-shares face Monday test after China PMI slides below 50

Intel stock price: INTC ends Friday lower — what to watch before Monday’s open
Next Story

Intel stock price: INTC ends Friday lower — what to watch before Monday’s open

Go toTop